Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cell Death & Disease|October 31, 2021
Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancerHanlin Yin, Ning Pu, Qiangda Chen, et al.
Cancer Medicine|July 24, 2022
Circulating cytokines allow for identification of malignant intraductal papillary mucinous neoplasms of the pancreasNing Pu, Qiangda Chen, Jicheng Zhang, et al.
International Journal of Surgery (London, England)|July 7, 2023
Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort studyNing Pu, Wenchuan Wu, Siyao Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 23, 2023
Tumor Microenvironment Responsive CD8<sup>+</sup> T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Based Synergistic Therapy for Pancreatic CancerQiangda Chen, Hanlin Yin, Junyi He, et al.
Annals of Translational Medicine|March 12, 2021
The effect of primary site, functional status and treatment modality on survival in gastroenteropancreatic neuroendocrine neoplasms with synchronous liver metastasis: a US population-based studyNing Pu, Joseph R Habib, Michael Bejjani, et al.
Annals of Translational Medicine|January 14, 2020
Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironmentNing Pu, Qiangda Chen, Shanshan Gao, et al.
Aging|September 10, 2020
Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, ChinaJie Chen, Xiaoping Xu, Jing Hu, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinomaQiangda Chen, Hanlin Yin, Siyao Liu, et al.
Journal for Immunotherapy of Cancer|March 26, 2024
Poor clinical outcomes and immunoevasive contexture in CD161<sup>+</sup>CD8<sup>+</sup> T cells barren human pancreatic cancerQiangda Chen, Hanlin Yin, Zhenlai Jiang, et al.
Therapeutic Advances in Medical Oncology|September 25, 2020
Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70Shanshan Gao, Ning Pu, Hanlin Yin, et al.
Pageof 3